136 related articles for article (PubMed ID: 16350444)
1. Cutaneous appendage tumors: familial cylindromatosis and associated tumors update.
Lian F; Cockerell CJ
Adv Dermatol; 2005; 21():217-34. PubMed ID: 16350444
[No Abstract] [Full Text] [Related]
2. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.
van den Ouweland AM; Elfferich P; Lamping R; van de Graaf R; van Veghel-Plandsoen MM; Franken SM; Houweling AC
Fam Cancer; 2011 Mar; 10(1):127-32. PubMed ID: 20972631
[TBL] [Abstract][Full Text] [Related]
3. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
Leonard N; Chaggar R; Jones C; Takahashi M; Nikitopoulou A; Lakhani SR
J Clin Pathol; 2001 Sep; 54(9):689-92. PubMed ID: 11533075
[TBL] [Abstract][Full Text] [Related]
5. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
Rajan N; Elliott R; Clewes O; Mackay A; Reis-Filho JS; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
Oncogene; 2011 Oct; 30(41):4243-60. PubMed ID: 21552290
[TBL] [Abstract][Full Text] [Related]
8. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene.
Zhang G; Huang Y; Yan K; Li W; Fan X; Liang Y; Sun L; Li H; Zhang S; Gao M; Du W; Yang S; Liu J; Zhang X
Exp Dermatol; 2006 Dec; 15(12):966-70. PubMed ID: 17083363
[TBL] [Abstract][Full Text] [Related]
9. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma and eccrine spiradenoma.
Chen M; Liu H; Fu X; Yu Y; Yu G; Tian H; Zhou G; Lu X; Chen S
Int J Dermatol; 2013 Dec; 52(12):1602-4. PubMed ID: 24261740
[No Abstract] [Full Text] [Related]
10. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome.
Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT
Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348
[TBL] [Abstract][Full Text] [Related]
11. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
[TBL] [Abstract][Full Text] [Related]
12. PLAG1 and CYLD do not play a role in the tumorigenesis of adenoid cystic carcinoma.
Daa T; Nakamura I; Yada N; Arakane S; Nishida H; Kashima K; Suzuki M; Yokoyama S
Mol Med Rep; 2013 Apr; 7(4):1086-90. PubMed ID: 23404581
[TBL] [Abstract][Full Text] [Related]
13. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.
Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248
[TBL] [Abstract][Full Text] [Related]
14. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ
Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826
[TBL] [Abstract][Full Text] [Related]
15. Brooke-Spiegler syndrome: report of a case of multiple cylindromas and trichoepitheliomas.
Doherty SD; Barrett TL; Joseph AK
Dermatol Online J; 2008 Jul; 14(7):8. PubMed ID: 18718192
[TBL] [Abstract][Full Text] [Related]
16. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages.
Poblete Gutiérrez P; Eggermann T; Höller D; Jugert FK; Beermann T; Grussendorf-Conen EI; Zerres K; Merk HF; Frank J
J Invest Dermatol; 2002 Aug; 119(2):527-31. PubMed ID: 12190880
[TBL] [Abstract][Full Text] [Related]
17. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.
Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT
J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188
[TBL] [Abstract][Full Text] [Related]
18. Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas.
Nasti S; Pastorino L; Bruno W; Gargiulo S; Battistuzzi L; Zavattaro E; Leigheb G; De Francesco V; Tulli A; Mari F; Scarrà GB; Ghiorzo P
Clin Genet; 2009 Nov; 76(5):481-5. PubMed ID: 19807742
[No Abstract] [Full Text] [Related]
19. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds.
Nagy N; Rajan N; Farkas K; Kinyó A; Kemény L; Széll M
Acta Derm Venereol; 2013 Nov; 93(6):743-5. PubMed ID: 23584127
[No Abstract] [Full Text] [Related]
20. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.
Massoumi R; Paus R
Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]